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SUMMARY
A trispanning orphan receptor (TOR) has been described in Schistosoma haematobium and S. mansoni. Here we report the
complete molecular organization of the S. mansoniTOR gene, also known as SmCRIT (complement C2 receptor inhibitor
trispanning). The SmTOR gene consists of 4 exons and 3 introns as shown by cloning the single exons from S. mansoni
genomic DNA and the corresponding cDNA from the larval stage (cercaria) and the adult worm. The SmTOR ORF
consists of 1260 bp and is longer than previously reported, with a fourth trans-membrane domain (proposed new name:
Tetraspanning Orphan Receptor) and with, however, an unchanged C2-binding domain on the extracellular domain 1
(ed1). This domain diﬀers in S. japonicum. A protein at the approximate expected molecular weight (55 kDa) was detected
in adult worm extracts with polyclonal andmonoclonal antibodies, andwas found to be expressed on the tegumental surface
of cercariae.
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INTRODUCTION
Schistosomiasis is a parasitic infection also known
as bilharzia named after Theodor Bilharz who ﬁrst
described it (Ross et al. 2002). There are 5 species
of schistosoma that are known to infect humans by
contact with its larval stage, the cercariae: Schisto-
soma mekongi, S. intercalatum, S. mansoni, S. japo-
nicum andS. haematobium, the latter 3 being themain
schistosome species that aﬀect humans (Hamburger
et al. 1998). Adult worm pairs reside in host veins
and produce eggs which penetrate the tissue. They
end up excreted with feces where they complete the
schistosoma life cycle by hatching and re-infecting
fresh-water snails as intermediate hosts (Ross et al.
2002). Between the mid-1990s and 2003 the esti-
mated number of people at risk from schistosomiasis
increased from 702 million to 779 million and the
estimated number of individuals infected increased
from 193 million to 207 million (Steinmann et al.
2006). The treatment of choice is the chemothera-
peutic agent praziquantel. However, drug treatment
alone might not be suﬃcient and a vaccine-linked
chemotherapy to control schisotomiasis is recom-
mended (Bergquist et al. 2005). Naturally acquired
immunity or vaccination in animals strongly dimin-
ishes the pathology associated with schistosome in-
fection. There are eﬀorts to develop a vaccine against
schistosomiasis. Radio-attenuated cercariae induced
a high level of protection in animal models (Minard
et al. 1978; Stek et al. 1981) and naturally resistant
population groups exist (Correa-Oliveira et al.
1989, 2000), which suggests that development of an
eﬀective vaccine is likely to be possible (McManus
and Loukas, 2008). There is a list of recombinant
proteins that correlate with resistance in human
studies and/or have shown eﬃcacy in animal models
(McManus and Loukas, 2008). Among these pro-
mising vaccine candidates are the tetraspanins,
SmTSP-1 and SmTSP-2, that are both recognized
by IgG1 and IgG3 from putatively resistant indi-
viduals, SmTSP-2 providing high level of protection
in the mouse vaccination model in addition (Tran
et al. 2006). Another candidate, Fatty Acid-Binding
Protein (FABP)-Sm14 is at the stage of planned
clinical trials after scale-up and industrial production
processes have been put in place (Tendler and
Simpson, 2008).
The host complement system participates in the
ﬁrst line of immune defences against the invading
parasite. Of the 3 pathways of complement acti-
vation, the alternative pathway was shown to attack
schistosomula (Ruppel et al. 1984; Pearce et al. 1990)
and S. mansoni adult worms (Linder and Huldt,
1983; Rasmussen and Kemp, 1987). Schistosomes
are sensitive to killing by complement, but lose
their sensitivity with loss of the glycocalyx and
maturation. Partial tryptic digestion of adult worm
tegumental proteins rendered them sensitive to
complement attack as shown for S. mansoni by
Fishelson’s group (Marikovsky et al. 1990). The
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mannose-binding lectin pathway has also been
shown to be activated (Klabunde et al. 2000), but
there has been no consensus regarding the activation
of the classical pathway. Some researchers ﬁnd IgG
(diﬀerent subtypes) and IgM deposits at the parasite
surface and some do not (Kemp et al. 1976, 1978,
1980). Identiﬁcation of host IgG1, IgG3, IgM, C3
degradation products (Braschi and Wilson, 2006)
and C4 (Braschi et al. 2006a), but no known proteins
with homology to Fc receptors by proteomic analysis
of the adult worm tegument, provide a strong argu-
ment for activation of the classical pathway (Braschi
et al. 2006a). In addition, there have been reports
of complement regulators being present on schisto-
somes, including C1q binding proteins, surface C3
receptor, host acquired DAF and SCIP-1/para-
myosin (Skelly, 2004), which might regulate the ter-
minal membrane attack complex insertion, although
this remains a matter of debate (Skelly and Wilson,
2006).
A speciﬁc surface receptor for C2, the Schistosoma
trispanning orphan receptor (TOR) was described
by Inal some time ago (Inal, 1999). In S. haema-
tobium andS. mansoniTORwas found to be a 32 kDa
trans-membrane protein located at the tegumental
surface of adult worms and was also expressed in the
larval stage (cercaria). Inal showed that a short amino
acid sequence of the ShTOR extracellular domain 1
(ed1) binds C2, resulting in competitive inhibition of
the binding of C2 to C4b. In addition it inhibits the
cleavage of C2 by C1s. Further experiments in-
dicated that this sequence was a strong inhibitor of
classical pathway activation. This sequence, corre-
sponding to the C-terminal 11 amino acids of ed1
(termedH17 peptide), has homologies with a speciﬁc
sequence of the beta chain of C4, which may explain
the competitive binding between H17 and C4 for C2
(Inal and Schiﬀerli, 2001, 2002). Hui et al. (2005)
deﬁned more precisely the binding site of H17 to be
the vWFA domain of C2. Therefore, TOR was re-
named CRIT for ‘complement C2 receptor inhibitor
trispanning’ (Inal and Sim, 2000; Inal et al. 2005b).
Recently, H17 was shown to interfere also with the
formation of the alternative pathway C3 convertase
by binding to FB (Hui et al. 2005, 2006). Evidently,
TOR might be a central element for schistosomes to
escape innate immunity.
Here we report the exon/intron structure of
the SmTOR gene. Four exons were ampliﬁed and
sequenced from S. mansoni genomic DNA based
on database analysis of the S. mansoni genome
and comparing it with S. japonicum TOR (SjTOR)
cDNA.The full-length construct was ampliﬁed from
the adult worm and cercarial cDNA preparations.
Further evidence for expression of the TOR protein
was gained by Western blotting with S. mansoni
proteins and probing these with antibodies directed
against the extracellular domain. Based on these re-
sults we propose a new structure of SmTOR/CRIT.
MATERIALS AND METHODS
Alignment of S. japonicum cDNA with S. mansoni
genome: derivation of SmTOR exon/intron gene
organization
SjTOR cDNA (PubMed Accession number AY-
814912; http://www.ncbi.nlm.nih.gov/) was aligned
with S. mansoni GeneDB database entry Smp_
093840 (http://www.genedb.org/genedb/smansoni/)
designated as a putative trispanning orphan receptor
gene. The resulting overlapping sequences served as
a basis to deﬁne SmTOR exon/intron boundaries.
PCR ampliﬁcation and sequencing of SmTOR
fragments from S. mansoni genomic DNA
S. mansoni genomic DNA was prepared from
cercariae-infected water. Cercariae in suspension
were washed by pelleting for 5 min at 1800 g and
resuspending in 1rPBS and an additional centri-
fugation step as before. The pellet was resuspended
in 1rTE (Fluka 86377)/100 mM NaCl and snap
frozen in liquid nitrogen. After thawing, 20% SDS
(Fluka 05030) and Proteinase K (Fluka 82456) were
added to a ﬁnal concentration of 1% and 1 mg/ml
respectively. The mixture was incubated at 60 xC
overnight. One volume of TE saturated phenol/
chloroform was added to the sample and mixed by
inversion for 15 min. After spinning at full speed in a
microfuge, the aqueous supernatant was transferred
to a new tube and the extraction step repeated twice,
but using chloroform only in the last cycle. DNA in
the aqueous phase was then precipitated by adding
1/10 (v/v) NaOAc, pH 5.5, overlaid with 2.5 volumes
of ethanol and incubating atx20 xCovernight.DNA
was pelleted at full speed, air-dried and resuspended
in 1rTE. Primers (Microsynth) ﬂanking the puta-
tive SmTOR exons were designed according to the
exon/intronmap (Table 1). PCRwas performedwith
Taq PCR core kit (Quiagen) using 0.75 mM speciﬁc
primers and 30 ng S. mansoni genomic DNA as
template. The PCR programme was 95 xC for 5 min,
then 35 cycles of 95 xC for 45 s, 59 xC for 1 min,
72 xC for 1 min followed by a ﬁnal extension step of
72 xC for 15 min. Reaction products were separated
by 1% agarose gel electrophoresis, excised bands
were puriﬁed (QIAquick1 PCR puriﬁcation kit) and
cloned into a TOPO vector (Invitrogen) for se-
quencing. Blanks for each PCR reaction using water
only were negative (not shown). All PCR products
were sequenced in both directions, using plasmid
preparations from 3 diﬀerent clones respectively.
RNA isolation from S. mansoni adult worms or
cercariae and full length cDNA preparation
S. mansoni RNA was isolated from adult worm
preparations of S. mansoni (Liberian strain, kindly
donated by Dr J. Chollet, STI, Basel) isolated from
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NMRI mice or cercariae. Worm pairs were brieﬂy
rinsed with 1rPBS and preserved in RNAlater1
reagent (Ambion). Worm tissue or cercariae were
homogenized by mechanical disruption with Mol-
ecular Grinding ResinTM (G-Biosciences) resuspend-
ed in lysis buﬀer RLT (AllPrepTM DNA/RNA/
Protein extraction kit, Quiagen). After removal of
resin and cell debris by centrifugation at 10 800 g,
for 5 min at 4 xC, the homogenate was applied on a
Quiagen AllPrep column and RNA extracted ac-
cording to the manufacturer’s protocol.
RT-PCR and cDNA alignment SmTOR/SjTOR
Single strand cDNA synthesis was performed using
random hexamers, oligo dT primers or gene speciﬁc
primer SmTOR_exon4_rev (Table 1). Fifty ng of
RNA was reverse transcribed per reaction with
SuperScriptTM III First-Strand Synthesis System
for RT-PCR (Invitrogen). Using the transcribed
single stranded cDNAs as a template, the SmTOR
transcribed sequence was ampliﬁed with gene
speciﬁc primer pair SmTOR_ex1_x15_fwd and
SmTOR_exon4_rev (Table 1) using the same cycling
conditions as described above. Reaction mixtures
were run on a 1% agarose gel and the single bands
puriﬁed, cloned and analysed as described above.
SmTOR ORF on sequenced cDNA was aligned
with SjTORORFon cDNA entry (AY814912) using
EMBOSS pairwise alignment algorithm (http://
www.ebi.ac.uk/emboss/align/).
Real-time quantitative PCR analysis (qPCR)
Total RNA was isolated from S. mansoni cercaria,
schistosomula, adult worm pairs, eggs and miracidia
as described above. Eggs and miracidia were isolated
as reported previously (Dalton et al. 1997). Schisto-
somula were generated by in vitro transformation
(Ramalhopinto et al. 1974). cDNA was generated as
described above and 1 ml per reaction was used,
performing qPCR on an ABI 7900 (Applied Bio-
systems) instrument using SYBR1 green as a ﬂuor-
escence dye (PowerSYBR1Green PCRMasterMix,
Applied Biosystems). Primers targeting a 219 bp
region of the constitutively expressed SmTPI (triose
phosphate isomerase) (Hooker and Brindley, 1996)
and primers used for SmTOR (SmTOR_ex1_x15_
fwd and SmTOR_ex2_+33_rev) are listed in
Table 1. Ampliﬁcation of contaminating genomic
DNA was avoided by using sets of primers located
in diﬀerent exons. Results were evaluated using the
2xDDCT method (Livak and Schmittgen, 2001).
Protein sequence alignment of S. japonicum and
S. mansoni TOR and secondary structure prediction
of SmTOR
Molecular weight analysis was performed using
the EMBOSS Pepstats program at the European
Bioinformatics Institute web site (http://www.ebi.
ac.uk/emboss/pepinfo). Proteins were aligned using
EMBOSS pairwise alignment algorithm (http://
www.ebi.ac.uk/emboss/align/). TopPred was used
for transmembrane prediction analysis (Claros and
Vonheijne, 1994) using upper cutoﬀ hydrophobicity
values. Secondary structure prediction analysis was
performed using PSIPREDView (Jones, 1999;
McGuﬃn et al. 2000). The signal sequence predic-
tion was performed using SignalP 3.0 server (http://
cbs.dtu.dk/services/SignalP).
Adult worm tegument membrane preparations and
Western blot analysis
Tegument surface membranes of S. mansoni adult
worms were prepared as done previously, applying
Table 1. Primer list used for ampliﬁcation of single exons of SmTOR and ampliﬁcations from cDNA
(Expected fragment lengths are indicated for primer pairs used to amplify single exons. Numbers used in the primer names
indicate its 5k annealing position within the exon or the ﬂanking intron, preceded by a positive or negative sign respectively,
if not annealing at the ends of the exons of interest due to issues of melting temperature when designing.)
Primer Sequence 5kp3k
Expected
product (bp)
SmTOR_ex1_x15_fwd GTCTCGTTAACTGTCGTTGTTGAATAATTG 246 bp
SmTOR_ex1_+12_rev TCTTGTCCTCTGATGGGTCTGTATTTCCAT 246 bp
SmTOR_ex2_x12_fwd TTCTACCCTAGGTTTTTATGTTTTCTCGAC 538 bp
SmTOR_ex2_rev TTTTGTGTGAATCATCAAGCGTAGATCTGA 538 bp
SmTOR_ex3_fwd ACGGGGCCTATTTACATCAAATCTACA 325 bp
SmTOR_ex3_rev CTCATACTTTGGTAGATCGTTAGCTGG 325 bp
SmTOR_exon4_7_fwd TATTGAAAATTCCGGCAAATGCCTACGCTC 248 bp
SmTOR_exon4_rev TTAGCAAGAAGAGTGAGCATTCGATGGTGC 248 bp
SmTPI_fwd GTTGGGGGGAACTGGAAAATGAA 219 bp
SmTPI_rev TTCTCCGGTGAATGCACCCTTTG 219 bp
SmTOR_ex1_x15_fwd GTCTCGTTAACTGTCGTTGTTGAATAATTG 291 bp
SmTOR_ex2_+33_rev ACAAGACGAAAGAGAGTCGAGAAAACATAA 291 bp
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the freeze-thaw method followed by vortex pulses in
order to strip the parasites (Roberts et al. 1983;
Brouwers et al. 1999). Samples were run on a stan-
dard 12% SDS-PAGE acrylamide/bisacrylamide
(30%/0.8%, Bio-Rad) gel and proteins then trans-
ferred to a nitrocellulose membrane (162-0115, Bio-
Rad). After blotting, the membrane was stained with
Ponceau red. Subsequently, the membrane was
blocked in1rPBS/0.05%Tween20 (Sigma)/5%milk
(170-6404 Bio-Rad) for 1 h at RT. Incubations with
primary and secondary antibodies described below
were done in 1rPBS/Tween 0.05%/1% blotting
milk (Bio-Rad) with 3washing steps of 5 min shaking
at RT before developing the blot. Two polyclonal
antibodies generated respectively against SmTOR
peptide ed1 NH2-MSPSLVSYTQKNERGSHEV-
KIKHFSP-COOH (Inal and Schiﬀerli, 2002) and
against ShCRIT peptide ed2 NH2-SSTSDIRL-
VIHTKTGPIYIKST-COOH 1 : 1000 were used
in PBS/T 1 : 1000 (Inal et al. 2005b), followed by
goat anti-rabbit IgG-HRP coupled (Bio-Rad, #170-
6515). The blot was developed using the ECLTM
Western blotting detection system (Amersham
Biosciences). Alternatively, a human monoclonal
antibody against SmTOR peptide ed1 isolated from
a human monoclonal antibody library (HuCAL) was
used at a dilution of 1 : 1000 (2.52 mg/ml stock) in
PBS/T (AbyD04644.1, AbD Serotec, Martinsried).
Mouse anti-Histidine-tag:HRP (MCA1396P, Sero-
tec) 1 : 3000 in PBS/T was used as secondary anti-
body and the blot revealed as described above.
The antibody was blocked by pre-incubation of
AbyD0644.1 with a 100-fold molar excess of ed1
peptide in PBS/T for 60 min at RT, and subsequent
steps were performed as described above.
Electron microscopy
Cercariae were ﬁxed in 3% paraformaldehyde and
0.5% glutaraldehyde in 10 mM PBS (pH 7.4). After
washing with PBS, they were treated with 0.5%OsO4
for 30 min followed by dehydration in a series
of graded ethanol solutions and embedding in LR
White resin at 60 xC.Ultrathin sections (60 nm)were
cut on an UltracutE Leica ulramicrotome and col-
lected on copper 200 mesh grids. Grids were blocked
in PBS/2% BSA for 2r5 min. Polyclonal anti-ed1 or
anti-ed2 antibodies described before were diluted in
blocking buﬀer (1 : 50) and pre-immune serum was
used as control. After incubation with primary anti-
bodies for 2 h, grids were washed twice for 5 min
with blocking buﬀer and incubated for 1 h with goat
anti-rabbit IgG (EM-GAHL10, British BioCell
Laboratories) diluted 1 : 20 in blocking buﬀer. Final
washings were performed followed by staining with
6% uranyl acetate, for 1 h, and then Millonigs lead
acetate for 2 min. The sections were then dried, ex-
amined and photographed using a Philips Morgani
transmission electron microscope.
Cryosections and immunolocalization
Thin sections (9 mm) of OCT-embedded frozen
S. mansoni cercariae were cut on a cryostat (Microm
HM 560) and ﬁxed in ice-cold methanol for 10 min.
After blocking in 1rPBS/3% BSA sections were
stained with monoclonal antibodies against ed1
(AbyD04644.1, described above) 1 : 50 in 1rPBS/
1% BSA or anti-GFP antibody (AbyD04652, AbD
Serotec, Martinsried, 1.14 mg/ml stock) diluted
to the according concentration for 2.5 h at RT. A
ﬂuorescein-labelled goat anti-human IgG F(abk)2
speciﬁc secondary antibody (# 109-095-006, Jackson
Immuno Research Laboratories) was used at a
dilution of 1 : 100 in PBS/BSA for 30 min at RT.
Slides were mounted with Vectashield ﬂuorescence
mounting medium (Vector Laboratories) and ex-
amined using LSM 510 META confocal laser scan-
ning microscopy system (Carl Zeiss, Feldbach,
Switzerland) with a Zeiss Plan Neoﬂuar 63x/1.25
numeric aperture oil (1/0.17) objective.
RESULTS
S. mansoni TOR gene comprises four exons
Thanks to S. mansoni genome sequence data pub-
lished on the GeneDB website, we performed an
alignment with S. japonicum mRNA sequence
available in the NCBI database in order to deﬁne
exon/intron boundaries of the SmTOR gene. The
analysis suggested that the SmTOR gene comprised
4 exons, instead of the 3 suggested in GeneDB.
Figure 1 represents the exon localizations along the
Sm genome, showing that the gene contains 3 introns
in the range of 2500 to 3500 bp, resulting in a 9721 bp
length gene. The hatched boxes in Sj mRNA rep-
resent the 5k and 3k untranslated regions. The re-
sulting transcript and protein would thus be longer
than observed before (Inal, 1999). Thanks to this
alignment, we were able to locate the ATG start
codon of the SmTOR gene Smp_093840 at position
60992 in scaﬀold Smp_scaﬀ000547.
Cloning and sequencing of SmTOR exons
We cloned the single exons from genomic DNA
extracted from S. mansoni cercariae using primers
ﬂanking the exons (Table 1). Separation of the PCR
products by agarose gel electrophoresis showed
bands at the expected size (Fig. 2A). The product for
the ampliﬁcation of exon 2 was expected to be 538 bp
long but appears to be about 50 bp smaller. After gel
extraction, cloning and sequencing of the single
bands, the PCR product of exon 2 was found to be
481 bp long. The diﬀerence of 50 bp is because part
of this region in the S. mansoniGeneDB is unknown
and designated as multiple NNN. The length and
sequencing results of the other 3 PCR products did
match the information deposited at the S. mansoni
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GeneDB database. All the fragments were cloned
at least 3 times and sequenced in both directions.
Sequencing results of the single exons are in com-
plete concordance with the cDNA sequence shown
below in an alignment with SjTOR cDNA (Fig. 3).
This delineation of sequencing information rep-
resents the merged information of single exon se-
quencing results. How the gained information is
related to the GeneDB entry is listed in the next
section.
Expression of full-length SmTOR
PCR ampliﬁcation of SmTOR ORF from cDNA
preparations from S. mansoni adult worms and cer-
cariae generated with diﬀerent primers (as described
above) yielded the same result for all the reactions.
Size-separation of reaction products ampliﬁed with
smTOR_ex1_x15_fwd and smTOR_exon4_rev
showed a single band at the expected size (Fig. 2B).
The gel-puriﬁed and cloned fragments all held the
1260 bp sequence coding for full length SmTOR.
The results were identical using diﬀerent clones and
performing sequencing reactions. The sequencing
result for SmTOR cDNA is shown in alignment with
SjTOR cDNA (AY814912) starting at the trans-
lation initiation codon (Fig. 3). When aligning the
results from the single exons described in the pre-
vious section with the sequenced SmTOR cDNA the
correlation was 100%. Splicing sites are marked with
black arrows on the SmTOR cDNA (Fig. 3).
Sequencing data for SmTOR cDNA perfectly
match the corresponding sequences in the S. mansoni
GeneDB database (positions 60 991 to 70 636,
scaﬀold Smp_scaﬀ000547) on S. mansoni genome
(starting at ATG on exon 1) for exons 1, 3 and 4
(single mutations diﬀering between the clones and
occuring at a frequency of 2 per 1260 bp were not
taken into account). The gap in the S. mansoni
GeneDB database lying within SmTOR exon 2
Fig. 2. Electrophoretic separation of PCR ampliﬁcation products from Schistosoma mansoni genomic DNA or adult
worm cDNA. (A) Lanes 1–4 correspond to PCR ampliﬁcation of exon 1–4 respectively, primers used Table 1.
(B) SmTOR ORF ampliﬁed from adult worm cDNA, primers: smTOR_ex1_x15_fwd, smTOR_exon4_rev (Table 1).
Fig. 1. Alignment of Sm (Schistosoma mansoni) genome (Smp_093840) and Sj (Schistosoma japonicum) mRNA of
CRIT. Representation of the gene structure of SmCRIT exons and introns. The grey boxes represent the exons,
the hatched boxes represent the sequences not found in Sm genome. Numbers indicate positions on scaﬀold
Smp_scaﬀ000547.
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(position 368–400 on SmTOR cDNA, 64816 to
64 908, Smp_scaﬀ000547 on S. mansoni GeneDB
entry Smp_093840) could be ﬁlled in (Fig. 3).
Furthermore, we found 13 single nucleotide diﬀer-
ences or gaps (indicated with stars in Fig. 3) within
exon 2 in the range of position 348 to 400 when
Fig. 3. SmTOR and SjTOR cDNA alignment; identical nucleotides are linked with a bar. Filled triangles indicate the
positions of splice site on SmTOR cDNA (positions 214/215, 684/685 and 1009/1010, numbering with respect to the
SmTOR start codon). Stars indicate mutations or gaps comparing sequencing data and GeneDB entry data; ATG of
smTOR 0.86 kb ORF (AF051138) is indicated by a triangle. Bases 368–400 were newly sequenced on Schistosoma
mansoni cDNA and from genomic DNA as described.
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comparing S. mansoni GeneDB sequence and
SmTOR cDNA. The newly sequenced SmTOR
cDNA compared with the shorter SmTOR mRNA
database entry (AF051138) of Inal (1999) was nearly
identical (18 single bases diﬀered; the ATG is
marked with a opened arrow (Fig. 3)). The former 5k
UTR region published at the same time for S. hae-
matobiumTOR (64 base pairs upstream of the former
ATG) matches the sequence we now ﬁnd to be part
of exon 2 of the longer SmTOR version, with only 5
bases being altered (not shown).
Developmental expression proﬁling of SmTOR
as compared to SmTPI showed that the receptor
mRNA was expressed at all the stages examined
(Fig. 4). The receptor was expressed at a higher level
in cercariae as compared to schistosomula, adult
worm, egg and miracidia.
The cDNA sequences aligned for S. mansoni and
S. japonicum TOR showed 46% homology at the
nucleotide level.
SmTOR translates into a protein similar in length
to SjTOR and possesses four transmembrane domains
SmTOR cDNA contains a 1260 bp open reading
frame which should generate a protein of 419 amino
acid length with a theoretical mass of 46.7 kDa.
Its amino acid sequence is shown in alignment with
SjTOR, a 414 amino acid protein based on pro-
teomics data (Liu et al. 2006). Protein alignment of a
possible SmTOR transcript and SjTOR shows
76.7% homology on the protein level (Fig. 5).
Based on results from transmembrane prediction
analysis we suggest SmTOR to have 4 transmem-
brane segments and a long C-terminal tail in hom-
ology with SjTOR (Fig. 6). In the absence of an
N-terminal signal peptide, the transmembrane do-
main 1 (aa 31–53, Fig. 6) ismost likely to function as a
signal anchor sequence for ER targeting and mem-
brane insertion, as predicted with the SignalP soft-
ware. The 4 transmembrane segments have an alpha
helical conformation predicted with high conﬁdence,
and the amphipatic alpha helix in the intracellular
domain 2 is likely to be partially inserted into the
plasma membrane. The domain organization is the
same for SmTOR and SjTOR. The overall trans-
membrane architecture remains the same as com-
pared to the truncated protein version (UniProtKB/
TrEMBL entry Q9U597) (Inal et al. 2005a, 2006).
The 11 amino acids in the C-terminal part of ed1
that have been described to bind to C2 and interfere
with its cleavage are boxed (Fig. 6). This sequence is
diﬀerent in SmTOR and SjTOR.
Performing Western blot analysis of adult worm
tegument preparations we detected a protein of about
55 kDa using antibodies generated against peptide
sequences of ed1 and ed2 (Fig. 7). The same result
was obtained using a monoclonal antibody generated
against ed1 (Fig. 8A). Staining of cryosections of
cercariae with the monoclonal antibody generated
against ed1 showed surface labelling, as compared
to the negative control (Fig. 8B). The presence of
SmTOR on the tegument surface was conﬁrmed by
electron microscopy. In sections stained with the
polyclonal antibodies against SmTOR ed1 and ed2
respectively, immunogold labelling was detected at
the tegument surface (Fig. 9).
DISCUSSION
The data presented here clarify the exon/intron gene
structure of SmTOR and provide evidence that
S. mansoni expresses the corresponding protein.
We found that SmTOR gene structure contains 4
exons. A transcript containing the 1.26 kb SmTOR
ORF showing 46% identity with the 1.25 kb SjTOR
ORF was found in adult worm and cercariae cDNA
preparations. The sequencing data generated not
only complete the gaps present in the S. mansoni
GeneDB for SmTOR, but also correct some likely
sequencing errors present in the database entry (stars
on SmTOR cDNA Fig. 3). The sequencing data
are likely to be correct. SmTOR ORF presented
here aligns with the previously described SmTOR
ORF on mRNA entry AF0511378 from position
418 on (alignment not shown), and translates into
a functional protein aligning with SjTOR. SmTOR
is expressed at various developmental stages of
S. mansoni. The highest expression was in cercariae,
where we were able to detect it at the surface by
confocal microscopy of cryosections and by electron
microscopy. The higher expression in cercariae as
compared to adult worms has previously been de-
scribed for the truncated receptor version (Inal,
1999). This observation is of interest since cercariae
are the ﬁrst to come into contact with the human skin,
an encounter that might determine the fate of the
Fig. 4. Quantitative RT-PCR analysis of SmTOR
mRNA in diﬀerent Schistosoma mansoni stages: (1) eggs,
(2) miracidiae, (3) cercariae, (4) schistosomulae, (5) adult
worm. Expression of SmTOR quantitated relative
to SmTPI as the control gene with bars representing
2xDDCT values.
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Fig. 5. SjTOR and SmTOR protein sequence alignment. Identical amino acids are linked with a bar (76.7% identity),
similar amino acids are connected via ‘ . . ’ (84% similarity). Exon/Intron boundaries on cDNA level for SmTOR are
indicated with ﬁlled triangles. SmTOR protein (AF051138) starting with former extracellular domain 1 is marked by a
triangle. Transmembrane domains 1–4 are shaded in grey as well as partially inserted helix 5. Domain designation: ed1,
new extracellular domain 1; ed2, extracellular domain 2; id1, id2 intracellular domains 1 and 2.
Fig. 6. SmTOR protein model according to data generated with TopPred and PSIPREDView program. Numbers
indicated refer to the ﬁrst and last amino acid of the corresponding intra- or extracellular domain. The peptide sequence
shown to bind C2 is boxed. Alphahelical transmembrane domains 1–4 are at positions 32–52, 165–185, 199–219 and
236–256 respectively. Transmembrane domain one acting as signal anchor is shaded in grey.
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infection. SmTOR might be essential at that speciﬁc
time-point. Many complement proteins are pro-
duced by epidermal cells (Timar et al. 2007) and
several authors have shown that complement pro-
teins diﬀuse from the vascular compartment to the
dermis and epidermis (Kool et al. 2007; Hansell et al.
2008). The complete complement cascade is active in
the skin as indicated by the role of complement in
many human blistering skin diseases (Lessey et al.
2008). SmTOR might at that time help the parasite
to escape complement attack.
We had previously not been able to replicate the
ampliﬁcation of the short version ORF of the TOR
receptor homologue from Schistosoma genomic
DNA or from vertebrate genomic DNA of various
sources (Inal et al. 2005b). This is now under-
standable since the gene has 3 large introns not
described previously. In addition, we did not ﬁnd the
sequence or fragments of it when performing
BLASTn searches on diﬀerent vertebrate genomes.
DeMarco et al. (2007) recently analysed the contro-
versy about the origin of schistosome albumin, and
demonstrated it to be of hamster origin. In his dis-
cussion, he suggested that CRIT might be an ex-
ample of reverse contamination from the schistosome
into the vertebrate samples. Our present data are in
agreement with DeMarco’s comments. We must
now consider our previous observations as being due
to contamination and non-speciﬁc antibody staining
(Inal et al. 2005a, b ; Moll et al. 2006).
Previously, for both ShTOR and SmTOR, tran-
scripts of 1.2 kb and 1.35 kb cloned from adult worm
cDNA libraries had been reported to contain an open
reading frame of 0.86 kb, as proteins of 31.7 and
31.2 kDa were detected in adult worm preparations
(Inal, 1999). Alignment of the region published as 5k
UTR of ShTOR (Inal, 1999) with SmTOR exon 2
sequenced resulted in a nearly perfect match (align-
ment not shown). SjTOR cDNA and protein (Liu
et al. 2006) are of the same length as we now found in
S. mansoni. We therefore suggest SmTOR to be
longer than originally described with the former
ATG lying within the second exon of the gene. The
translation initiation site we suggest for SmTOR
does not lie in a classical Kozak sequence (Kozak,
1984), but possible variation around the translation
initiation codon has been reported for invertebrates
(Nakagawa, 2008).
TOR protein had been shown on the surface of the
adult worm by immunohistochemistry (Inal, 1999).
We detected a band at approximately 55 kDa in
adult worm tegument membrane preparation using
2 diﬀerent polyclonal antibodies generated against
ed1 and ed2 respectively. The SmTOR amino acid
sequence contains a potential N-linked glycosylation
site at position 138. The protein detected might
be the glycosylated form, as its theoretical molecular
weight was calculated as 46.7 kDa. SmTOR in
alignment with SjTOR protein shows 76% identity
and 84% similarity. TOR was found by Liu in
S. japonicum in cercariae, schistosomula and adult
worm (Liu et al. 2006), whereas no proteomic
analysis of the schistosome tegument of adult worms
identiﬁed peptides belonging to SmTOR (van
Balkom et al. 2005; Braschi et al. 2006b ; Braschi and
Wilson, 2006). This might be due to the low abun-
dance of the protein in the tegument of the adult
worm (Skelly and Wilson, 2006).
Based on the secondary structure analysis de-
scribed above we generated a hypothetical protein
model for SmTOR. SmTOR (or CRIT) was pre-
viously thought to span themembrane 3 times (hence
the ‘T’ for rispanning). The longer protein we found
is very likely to be tetraspanning, as suggested also
for SjTOR, which allows us to suggest a change in
the name of themolecule, but without a change in the
abbreviations used. The amphiphatic helix inserted
partially in the membrane is present in SjTOR and
SmTOR, although there is high variability of amino
acid sequence at this site between the two species.
SmTOR had been renamed to CRIT (comp-
lement C2 receptor inhibitor trispanning) according
to its putative function to bind C2. The former
N-terminal extracellular domain ed1 of ShTOR
as isolated peptide had been shown to bind C2 and
with its C-terminal 11 amino acids designated as
H17 peptide being the active binding site (Inal and
Schiﬀerli, 2002). Incubation with this peptide has
been shown to interfere with the binding of C2 to
C4b and with C2 cleavage by complement C1s, thus
blocking complement activation by the classical
pathway. The new tetraspanning SmTOR protein
still contains the same amino acid sequence in the
extracellular domain 1 known to bind C2. Whether
this sequence binds C2 in vivo on schistosomes
remains to be explored, and it is interesting to note
several diﬀerences in it between S. mansoni and
S. japonicum. It will be interesting to test whether
these diﬀerences alter C2 binding to TOR/CRIT.
Fig. 7. Western blot of adult worm tegument
preparation. Polyclonal anti-ed1, anti-ed2 antibody and
pre-immune serum (lanes 1, 2 and 3 respectively).
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Fig. 8. SmTOR detection with a monoclonal anti-ed1 antibody AbyD04644.1. (A) Adult worm tegument preparation.
Western blot probed with monoclonal anti-ed1 (lane 1) or anti-ed1 pre-incubated with 100-fold excess of ed1 peptide as
control (lane 2). (B) Immunoﬂuorescent labelling of cryosections through cercariae. Anti-ed1 labelled section top left
panel and anti-GFP labelled control section bottom left panel.
Fig. 9. Localization of SmTOR on tegument of cercariae using electron microscopy. Immunogold labelling is
indicated by arrows. Sections stained with (A) polyclonal anti-ed1 antibody, (B) polyclonal anti-ed2 antibody and
(C) pre-immune serum. Secondary antibody only was negative (not shown).
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